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Welcome to the Webinar 
Individualized Treatment and the 
Non-Pharmacologic 
Components of Recovery 
How To Connect to Webinar Audio
To receive a call back, provide your phone number when you join the event, or call the number below and enter the 
access code 624 494 571
Call-in toll number (US/Canada) 1-650-479-3208. 
This Webinar is being recorded. To view the captions for this event click on the URL below.
http://livewrite-ncc.appspot.com/attend?event=citwebex
Do any of these myths strike a 
cord with you? While we are 
waiting to begin….
If you feel comfortable, share your 
thoughts about these myths in the 
chat box. 
5 Common Myths About 
Substance Use Disorder
Susan Halpin
susan.halpin@umassmed.edu
National Network of Libraries of Medicine (NNLM), 
New England Region (NER) 
Education & Outreach Coordinator
University of Massachusetts 
Medical School 
Worcester, Massachusetts
Your Webinar Host
Webinar Learning Objectives
• Become familiar with the National Library of Medicine (NLM) and its free, 
digital resources
• Understand the how the NLM provides outreach by the National Network of 
Libraries of Medicine (NNLM) through comprehensive online resources, training 
classes and grant funding opportunities.
• Understand the rationale and treatment options for managed withdrawal of a 
patient with opioid use disorder.
• Understand the rationale and treatment options for Medication Assisted 
Treatment in a patient with opioid use disorder.
• Understand the non-pharmacologic components that are part of recovery.
NLMs mission 
Advance the progress of medicine and improve public health by making biomedical 
information accessible to everyone.
The NLM physical library 
is Bethesda, MD on the 
NIH campus. 
NLM is the largest 
biomedical library in the 
world
NLM is one of the federal 
government’s largest 
providers of digital content
The library is open to 
everyone. All of its 
resources are FREE.
• Nationwide network of health sciences 
libraries, public libraries & information 
centers 
• Each region has a partnership with a 
regional medical library
• Outreach provided through 
Free access to online health & medical  resources
Free Training & Professional Development
Grant funding opportunities
NLM Implements Outreach 
Through the National Network of Libraries of Medicine (NNLM)
NNLM has about 6800 
Network Members.
Members are 
• Librarians, 
• Healthcare providers, 
• Public health professionals
• K-12 Educators and students
• Consumers
Anyone can join the network, 
it’s FREE
Joining the network provides you access to 
training classes and grant funding 
opportunities
To Join the NNLM Network :
https://nnlm.gov/members/join-network
https://nnlm.gov/
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Outline
• Epidemiology
• Longitudinal outcomes
• Preventive efforts
• Treatment
• Conclusions
• Recovery elements
Epidemiology
NSDUH, 2014
Drug overdose deaths involving opioids by type of opioid
United States, 2000–2014
CDC, 2016
Prescription Opioids and Heroin use during the Previous Year
United States, 2000–2014.
Comptom, 2016
Prescription Opioids and Heroin Drug Poisoning 
United States, 2000–2014.
Comptom, 2016
Main medical diagnosis 
UMMC Worcester MA: 2008-2012
Ross et al, unpublished
Ross et al, unpublished
Last treating services 
UMMC Worcester MA: 2008-2012
Source Where Pain Killers Were Obtained
Age 12 or Older: 2010-2011 

Substance use disorders (DSM-5)
• Neuroadaptation:
Tolerance
Withdrawal
• Cognitive distortion:
Importance of  substance use
Subjective awareness of decrease control
Craving or a strong desire or urge to use 
• Behavioral dyscontrol:
Obtaining, using and recovering
Use despite knowledge of problems
Using more and longer than intended
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Preventive efforts
Preventive efforts
• Education of medical and nursing students on 
universal precautions with controlled substances
• Prescription guidelines for practicing physicians and 
dentists on safe pain management
• Prescription monitoring program (PMP)
• Safe storage of opioid analgesics (locked box)
• Appropriate disposal of unused opioid analgesics
• Naloxone rescue kits available (standing orders) 
Treatment
• The proportion of all clients receiving methadone was 22 to 25 percent 
between 2006 and 2010.
• The proportion of clients receiving buprenorphine was 1 percent or less from 
2006 to 2008, but increased to 2 percent in 2009 and 2010.
Patients in Treatment, by type of  care received: 2006-2010
Substance use disorder treatment services
1. Detoxification / stabilization units (ATS)
2. Inpatient acute hospitalization 
3. Nonhospital residential rehabilitation (CSS)
4. Partial hospital day Program (PHP)
Intensive outpatient program (IOP) 
5.   Outpatient treatment / office-based
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Psychosocial treatments  
1. Drug Counseling
2. Motivational Enhancement Therapy
3. Relapse prevention
4. Cognitive Behavioral Therapy
5. Mindfulness base treatment
6. Contingency Management
7. Twelve Steps facilitation
8. Self-help groups
Let’s expand our view.
Use of Medications
Managed withdrawal (ATS)
• In-patient stabilization units
• Reduce opioid withdrawal symptoms
• Transition off daily opioid use
• Evaluate and treat comorbid medical 
and psychiatric problems
• Usually 4-5 days  needs follow-up
• Reduction of the intensity of opioid withdrawal
• 1 or 2 attempts are reasonable
• Should be considered initial step in recovery
• Efficacy alone is very low ( less 20%) 
• Efficacy improves with IOP or PHP
• ATS is not necessary to start MAT
Managed withdrawal (ATS)
• Clonidine protocol  Naltrexone (IM)
• Buprenorphine protocol  
• Methadone protocol
Managed withdrawal (ATS)
• Joint selection of protocol is helpful for engagement
• Motivation enhancement for treatment is needed
• Challenges include wide variation of motivation for 
treatment and risk of use while on the unit.
Medication assisted treatment (MAT)
• Outpatient settings
• Suppress opioid withdrawal symptoms
• Suppress craving for opioids
• Stop opioid use and relapse
• Adjust daily dose to avoid sedation
Medication assisted treatment (MAT)
• Naltrexone (PO and IM)
• Buprenorphine + Naloxone
• Methadone
Naltrexone
• Indications: Severe opioid use disorder
• Mechanism: Opiate receptor antagonist
• Efficacy: Oral is good in high motivated.
• Implementation: 50-100 mg/per day; LFT’s
• Side effects : nausea, headache, anxiety, OD
• Compliance: Improved with naltrexone depot (IM) 
(Comer, 2006; Krupitsky, 2011)
Naltrexone Depot
Krupitsky, 2011
Methadone
• Indications: Severe opiate use disorder
• Mechanism: Full opiate receptor agonist.
• Efficacy: 70-80 % retention in OTP.
• Implementation: Start at 25-30mg and built-up 
dose until opiate free urines. 
• Side effects : sedation
• Interactions: benzodiazepine – alcohol.
Methadone
• Age >18 or 2 documented failures of detox.
• One year history of severe opiate use disorder
• Exceptions:
Pregnancy
Release from prison
History of previous treatment.
Strain, 1999
Methadone dose: illicit opioid use
Buprenorphine
• Partial opiate receptor agonist
• Combination tablet /film (Bup/naloxone)
• Sublingual administration
• High affinity and slow dissociation
• Office based opiate use treatment
• Death associated with IV use and with 
benzodiazepines

MAT – Buprenorphine - Naloxone
Romero-Gonzalez et al, 2017
Treatment of  opioid dependent youth
Woody, 2008
Buprenorphine and Memantine for young adults
Gonzalez, 2015
Long-term outcomes
Long-term outcomes
• Reduction of mortality compared to untreated 
controls (Gronbladh, 1990)
• Decrease IVDU from 81% to 29% vs 82% at 1 
year of those who left treatment (Ball and Ross, 1991)
• HIV seroconversion: methadone 3.5% vs active 
IVDU 22% 
Prevalence of  past month heroin use, 
heroin dependence and other drug use across the 
11-year follow-up period
Teesson, 2015
Comorbid disorders impact
Major Depression * 1.96 (1.50 – 2.55)
Antisocial Personality 1.02 (0.70 – 1.32)
Borderline Personality 1.16 (0.91 – 1.48)
PTSD 0.81 (0.63 – 1.05)
Teesson, 2015
Teesson, 2015
Treatment  effect
MAT 1.11 (0.90 – 1.38)
Detoxification * 1.52 (1.20 – 1.92)
Residential Rehab * 0.59 (0.46 – 0.76)
Teesson, 2015
Teesson, 2015

NON-PHARMACOLGIC COMPONENTS OF 
RECOVERY
ASAM criteria: 
• Dimension 1: Acute intoxication/withdrawal potential
• Dimension 2: Biomedical complications
• Dimension 3: Emotional, behavioral or cognitive 
complications; co-occurring disorders 
• Dimension 4: Readiness to change 
• Dimension 5: Relapse, Continued use potential
• Dimension 6: Recovery environment 
COMPONENTS OF RECOVERY
• EBP recognizes that treatment should be 
individualized based on a comprehensive 
assessment
• Offering a continuum of care allows for more time to 
address major life problems requiring continued 
work from the individual, such as:
– Homelessness
– Legal issues
– Family and interpersonal struggles
– Education and vocational training
– Life skills 
• Case Management services are critical  
• Current opioid use epidemic is responsibility of 
all to help reduce.
• Education and change in prescription practices 
are key elements in prevention.
• Reduction of diversion and appropriate disposal 
is important.
• Stabilization treatment alone is not effective
• Medication - assisted treatments are effective.
• There is still need to develop effective short-term 
treatments.
Conclusion

Opiate Addiction & Treatment Portal 
https://sis.nlm.nih.gov/enviro/addiction.html#a7
Handy NLM Tool To Identify a Pill
https://pillbox.nlm.nih.gov/pillimage/search.php
https://medlineplus.gov/
NLM Resources Related to Mental and 
Behavioral Health
https://mentalhealth.gov/
https://www.nlm.nih.gov
Offering programming on addiction and 
recovery? Consider borrowing one of our 
Graphic Medicine Book Club Kits featuring 
Sobriety: A Graphic Novel! 
From the publisher… 
“Through rich illustration 
and narrative, Sobriety: 
A Graphic Novel offers 
an inside look into 
recovery from the 
perspectives of five 
Twelve Step group 
members, each with a 
unique set of addictions, 
philosophies, struggles, 
and successes while 
working the Steps.”
To Request a Kit: 
www.nnlm.gov/ner/kits
For Questions or Further Information, 
Contact Matthew Noe at 
Matthew.Noe@umassmed.edu
Promotional Items & Printable Handouts
https://sis.nlm.nih.gov/outreach/promotional_materials.html
Thank you all for attending this webinar!
Thank you Dr. Gonzalez and Lindsey for 
sharing your experience and  knowledge!
Please complete the webinar evaluation to receive MLA credit
http://www.surveygizmo.com/s3/3529624/62b1b6a48e79 
For more information about how you can benefit from NNLM NER outreach contact 
Susan Halpin, Education & Outreach Coordinator
susan.halpin@umassmed.edu
I am planning the next series of webinars about Substance Use Disorder. 
Is there a topic you would like to learn about? Let me know.
